Cancer-associated thrombosis: the when, how and why
Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognised both for physicians that deal with venous thromboembolism (VTE) and for oncologists. It is currently estimated that the annual incidence of VTE in patients with cancer is 0.5% compared to 0.1% in th...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2019-03-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/28/151/180119.full |
| _version_ | 1818603591397539840 |
|---|---|
| author | Caio J. Fernandes Luciana T. K. Morinaga José L. Alves Marcela A. Castro Daniela Calderaro Carlos V. P. Jardim Rogerio Souza |
| author_facet | Caio J. Fernandes Luciana T. K. Morinaga José L. Alves Marcela A. Castro Daniela Calderaro Carlos V. P. Jardim Rogerio Souza |
| author_sort | Caio J. Fernandes |
| collection | DOAJ |
| description | Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognised both for physicians that deal with venous thromboembolism (VTE) and for oncologists. It is currently estimated that the annual incidence of VTE in patients with cancer is 0.5% compared to 0.1% in the general population. Active cancer accounts for 20% of the overall incidence of VTE. Of note, VTE is the second most prevalent cause of death in cancer, second only to the progression of the disease, and cancer is the most prevalent cause of deaths in VTE patients. Nevertheless, CAT presents several peculiarities that distinguish it from other VTE, both in pathophysiology mechanisms, risk factors and especially in treatment, which need to be considered. CAT data will be reviewed in this review. |
| first_indexed | 2024-12-16T13:25:36Z |
| format | Article |
| id | doaj.art-e9cc105a27c6433580e740ea1e018275 |
| institution | Directory Open Access Journal |
| issn | 0905-9180 1600-0617 |
| language | English |
| last_indexed | 2024-12-16T13:25:36Z |
| publishDate | 2019-03-01 |
| publisher | European Respiratory Society |
| record_format | Article |
| series | European Respiratory Review |
| spelling | doaj.art-e9cc105a27c6433580e740ea1e0182752022-12-21T22:30:14ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172019-03-012815110.1183/16000617.0119-20180119-2018Cancer-associated thrombosis: the when, how and whyCaio J. Fernandes0Luciana T. K. Morinaga1José L. Alves2Marcela A. Castro3Daniela Calderaro4Carlos V. P. Jardim5Rogerio Souza6 Dept of Cardiopulmonology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil Dept of Cardiopulmonology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil Dept of Cardiopulmonology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil Dept of Cardiopulmonology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil Dept of Cardiopulmonology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil Dept of Cardiopulmonology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil Dept of Cardiopulmonology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognised both for physicians that deal with venous thromboembolism (VTE) and for oncologists. It is currently estimated that the annual incidence of VTE in patients with cancer is 0.5% compared to 0.1% in the general population. Active cancer accounts for 20% of the overall incidence of VTE. Of note, VTE is the second most prevalent cause of death in cancer, second only to the progression of the disease, and cancer is the most prevalent cause of deaths in VTE patients. Nevertheless, CAT presents several peculiarities that distinguish it from other VTE, both in pathophysiology mechanisms, risk factors and especially in treatment, which need to be considered. CAT data will be reviewed in this review.http://err.ersjournals.com/content/28/151/180119.full |
| spellingShingle | Caio J. Fernandes Luciana T. K. Morinaga José L. Alves Marcela A. Castro Daniela Calderaro Carlos V. P. Jardim Rogerio Souza Cancer-associated thrombosis: the when, how and why European Respiratory Review |
| title | Cancer-associated thrombosis: the when, how and why |
| title_full | Cancer-associated thrombosis: the when, how and why |
| title_fullStr | Cancer-associated thrombosis: the when, how and why |
| title_full_unstemmed | Cancer-associated thrombosis: the when, how and why |
| title_short | Cancer-associated thrombosis: the when, how and why |
| title_sort | cancer associated thrombosis the when how and why |
| url | http://err.ersjournals.com/content/28/151/180119.full |
| work_keys_str_mv | AT caiojfernandes cancerassociatedthrombosisthewhenhowandwhy AT lucianatkmorinaga cancerassociatedthrombosisthewhenhowandwhy AT joselalves cancerassociatedthrombosisthewhenhowandwhy AT marcelaacastro cancerassociatedthrombosisthewhenhowandwhy AT danielacalderaro cancerassociatedthrombosisthewhenhowandwhy AT carlosvpjardim cancerassociatedthrombosisthewhenhowandwhy AT rogeriosouza cancerassociatedthrombosisthewhenhowandwhy |